LENZ Therapeutics, Inc.
LENZ
$7.34
$0.050.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.49M | -35.90M | -16.70M | -14.91M | -14.62M |
| Total Depreciation and Amortization | 111.00K | 107.00K | 125.00K | 19.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.42M | 3.27M | 2.69M | 1.96M | 1.50M |
| Change in Net Operating Assets | 3.38M | -503.00K | 5.30M | 1.43M | -2.97M |
| Cash from Operations | -33.58M | -33.03M | -8.59M | -11.51M | -16.05M |
| Capital Expenditure | -18.00K | -38.00K | -439.00K | -240.00K | -110.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.18M | -89.77M | -3.89M | -174.00K | 19.00M |
| Cash from Investing | 33.16M | -89.81M | -4.33M | -414.00K | 18.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.00K | 122.62M | 598.00K | 26.49M | 44.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.00K | 122.62M | 598.00K | 26.49M | 44.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -407.00K | -220.00K | -12.32M | 14.57M | 2.88M |